NALO Therapeutics Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
6
- Latest Deal Type
-
Out of Business
NALO Therapeutics General Information
Description
Developer of pharmaceutical products intended to treat hematological and solid tumors. The company's products are small molecule-based medicines for the treatment of cancer and are high-value disease drivers and target major unmet needs in oncology, enabling patients with medicines to treat cancer cells that originate from uncontrolled cellular growth.
Contact Information
Website
www.nalotherapeutics.comCorporate Office
- 628 Middlefield Road
- Palo Alto, CA 94301
- United States
Corporate Office
- 628 Middlefield Road
- Palo Alto, CA 94301
- United States
NALO Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 03-Oct-2025 | Completed | Out of Business | |||
| 2. Early Stage VC | 01-May-2020 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
NALO Therapeutics Patents
NALO Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025175145-A1 | N-(1-((r)-1-acryloylazepan-3-yl)-7-chloro-6-(((r)-tetrahydrofuran-3-yl)oxy)-1h-b enzo[d]imidazol-2-yl)-2-methylisonicotinamide (nx-019) for use in the treatment of egfr mutant cancer | Pending | 14-Feb-2024 | ||
| WO-2025043063-A1 | Modulators of myc family proto-oncogene protein | Inactive | 24-Aug-2023 | ||
| WO-2025043065-A1 | Modulators of myc family proto-oncogene protein | Inactive | 24-Aug-2023 | ||
| WO-2024206628-A1 | Modulators of myc family proto-oncogene protein | Inactive | 30-Mar-2023 | ||
| WO-2024206628-A4 | Modulators of myc family proto-oncogene protein | Inactive | 30-Mar-2023 | C07D493/08 |
NALO Therapeutics Signals
NALO Therapeutics FAQs
-
When was NALO Therapeutics founded?
NALO Therapeutics was founded in 2017.
-
Where is NALO Therapeutics headquartered?
NALO Therapeutics is headquartered in Palo Alto, CA.
-
What is the size of NALO Therapeutics?
NALO Therapeutics has 6 total employees.
-
What industry is NALO Therapeutics in?
NALO Therapeutics’s primary industry is Drug Discovery.
-
Is NALO Therapeutics a private or public company?
NALO Therapeutics is a Private company.
-
What is NALO Therapeutics’s current revenue?
The current revenue for NALO Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process